Multi-Year Study of Fluzone High-Dose Influenza Vaccine Compared With Fluzone® Vaccine in Adults Aged 65 Years and Older

NCT00976027 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
9172
Enrollment
INDUSTRY
Sponsor class

Stopped No safety concerns, study terminated due to lack of primary endpoint cases in 2009-2010 Flu season (coincided with H1N1 Pandemic) Subjects followed per-protocol

Conditions

Interventions

Sponsor

Sanofi